MASI

Masimo Corp

Healthcare


Presented:06/13/2023
Price:$160.02
Cap:$8.45B
Current Price:$143.93
Cap:$7.70B

Presented

Date06/13/2023
Price$160.02
Market Cap$8.45B
Ent Value$10.87B
P/E Ratio73.56x
Book Value$25.20
Div Yield0%
Shares O/S52.78M
Ave Daily Vol399,438
Short Int4.98%

Current

Price$143.93
Market Cap$7.70B
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Publicly traded companies mentioned herein: Apple (APPL), Garmin (GRMN), Masimo Corp (MASI), Medtronic PLC (MDT) 

Highlights

The presenter is long shares of Masimo Corp (MASI) which is a leading player in the MedTech industry, particularly in hospitals. Two decades ago, the market was dominated by a company called El Core, which is now part of Medtronic. However, Masimo emerged with superior products and marketing strategies, capturing a significant market share. More recently the stock endured a steep selloff as Covid tailwinds rolled off combined with the announcement of their acquisition of Sound United. Despite these issues, the presenter sees ways for the stock to outperform: there may ultimately be sound industrial logic to their entrance into consumer health; MASI may be able to monetize its legal battle with Apple; and the company has an activist who will likely keep pressure on management to perform.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.